Tower Research Capital »

Y Mabs Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $55k 3.4k 16.26
2023-09-30 $8.2k 1.5k 5.44
2023-06-30 $9.6k 1.4k 6.79
2023-03-31 $30k 5.9k 5.06
2022-12-31 $3.0k 576 5.21
2022-09-30 $23k 1.6k 14.52
2022-06-30 $63k 4.2k 15.06
2022-03-31 $34k 2.9k 11.81
2021-12-31 $53k 3.2k 16.64
2021-09-30 $64k 2.2k 28.53
2021-06-30 $61k 1.8k 33.98
2021-03-31 $122k 4.0k 30.11
2020-12-31 $138k 2.8k 49.34
2020-09-30 $37k 967 38.26
2020-06-30 $116k 2.7k 43.24
2019-12-31 $17k 552 30.80
2019-06-30 $17k 740 22.97
2019-03-31 $6.0k 215 27.91
2018-12-31 $7.0k 357 19.61